Skip to main content
. 2006 Sep;8(9):702–707. doi: 10.1593/neo.06277

Table 2.

Level of c-myc Amplification in the Whole Population (n = 84 Eligible Primary Resected Barrett Cancer Cases Investigated with CISH) and in Subgroups.

n No Amplification [n (%)] Low-Level Amplification [n (%)] High-Level Amplification [n (%)] P (Chi-Square Analysis)
Whole population 84 14 (16.7) 63 (75.0) 7 (8.3)
Subgroups Age (years)
< 64 45 6 (13.3) 34 (75.6) 5 (11.1) ns
> 64 39 8 (20.5) 29 (74.4) 2 (5.1)
Sex
Male 78 14 (18.0) 57 (73.1) 7 (9.0) ns
Female 6 0 6 (100.0) 0
Tumor size* (mm)
< 50 52 7 (13.5) 38 (75.0) 6 (11.5) ns
> 50 32 6 (18.8) 25 (78.1) 1 (3.1)
Depth of invasion (pT category)
pT1/2 47 8 (9.5) 34 (40.5) 5 (6.0) ns
pT3/4 37 6 (7.1) 29 (34.5) 2 (2.4)
Lymph node involvement (pN category)
pN0 40 8 (20.0) 28 (70.0) 4 (10.0) ns
pN1 44 6 (13.6) 35 (79.6) 3 (6.8)
Lymphatic vessel invasion (L category)
L0 59 11 (18.6) 45 (76.3) 3(5.1) ns
L1 25 3 (12.0) 18 (72.0) 4 (16.0)
UICC stage
I/II 55 9 (16.4) 40 (72.7) 6 (10.9) ns
III/IV 29 5 (17.2) 23 (79.3) 1 (3.5)
Differentiation (grade)
G1/2 41 6 (14.6) 33 (80.5) 2 (4.9) ns
G3/4 43 8 (18.6) 30 (69.8) 5 (11.6)
Lauren classification
Diffuse 2 0 1 (50.0) 1 (50.0) .0466
Intestinal 74 14 (18.9) 56 (75.7) 4 (5.4)
Mixed 8 0 6 (75.0) 2 (25.0)
*

Size range: 5 to 130 mm.